Investor Fraud Suit Against Husch Blackwell, Partner Revived

Husch Blackwell LLP and one of its partners must face revived fraud and negligence claims brought by investors duped in a pharmaceutical investment scheme by a Husch client, after a New...

Already a subscriber? Click here to view full article